作者: Sara Tannenbaum , Gabriel T. Sayer
DOI: 10.1097/HCO.0000000000000163
关键词: Cardiology 、 Heart failure with preserved ejection fraction 、 Medicine 、 Pathophysiology 、 Internal medicine 、 Cardiology and Cardiovascular Medicine
摘要: Purpose of reviewWith the failure multiple trials to identify a successful therapy for heart with preserved ejection fraction (HFpEF), attention has shifted defining specific phenotypes within HFpEF spectrum in an effort develop targeted approach treatment. Here we summariz